Polymer-free Amphilimus™ (Sirolimus + Fatty Acid) eluting stent for lesions in the SFA region.
The absence of polymer minimizes the risk of inflammation/thrombosis, while the proprietary formulation enhances drug absorption.
The proprietary polymer-free Abluminal Reservoir Technology allows a sustained drug release, exclusively towards the vessel wall, up to 3 months, eliminating the renowned drawback associated to the polymers
The Amphilimus™ formulation (Sirolimus + Fatty Acid) enhances drug bioavailability, permeability and maximizes product overall safety and efficacy
Thanks to its haemo and bio- compatibility, the Bio Inducer Surface acts as anti-thrombotic coating and it promotes a fast-healing sealing against heavy metal ions release
The images shown within this pages are of a purely illustrative nature and not intended to depict reality.
Manufactured by CID S.p.A member of Alvimedica Group.